Open this publication in new window or tab >>Show others...
2026 (English)In: Pulse, ISSN 2235-8676, Vol. 14, no 1, p. 1-11Article in journal (Refereed) Published
Abstract [en]
Introduction: Hypertension is linked to endothelial dysfunction, but causality and direction is not entirely known. The aim was to study the cross-sectional associations between home, office, and central BP and microcirculatory peak oxygen saturation (OxyP). Methods: In the observational Swedish CArdioPulmonary bioImage Study (SCAPIS) Linköping subsample, office and home BP were measured using an oscillometric device and OxyP was measured in forearm skin after a 5-min occlusion of the brachial artery. A linear regression was fitted to evaluate the mean change in OxyP per SD increase in BP. A logistic regression was fitted to evaluate the associations between BP above the median and OxyP below the median. Results: Of participants, 3,291 were included in the analyses. Per SD increase in systolic home BP, the adjusted mean (95% CI) difference in OxyP was −0.4 (−0.6 to −0.1%). In subgroup analyses, the association remained for women but not men, although the interaction by sex was not statistically significant. Also, in women but not in men, OxyP was lower in those with white coat hypertension vs. sustained normotension, i.e., mean (95% CI) 88.8 (88.2–89.4%) vs. 89.6 (89.3–90.0%), and in those with masked hypertension vs. sustained normotension, i.e., 87.5 (85.9–89.1%) vs. 89.6 (89.3–90.0%). Conclusion: Home BP, which better predicts cardiovascular disease than office BP, was inversely associated with OxyP. This correlation remained in subgroup analyses of women but not men, suggesting possible sex-dependent microcirculatory dysfunction or that masked hypertension could be a more important cardiovascular risk marker in women, despite its higher prevalence in men.
Keywords
Blood pressure, Cardiovascular disease, Inflammation, Microcirculation, Peak oxygen saturation
National Category
Cardiology and Cardiovascular Disease
Identifiers
urn:nbn:se:liu:diva-220196 (URN)10.1159/000549752 (DOI)001650915200001 ()41439169 (PubMedID)
Note
Funding Agencies|Swedish Heart and Lung Foundation [2016-0315]; Knut and Alice Wallenberg Foundation [2014-0047]; Swedish Research Council [822-2013-2000]; Vinnova (Sweden's Innovation Agency) [2012-04476]; Vinnova (Sweden's Innovation Agency) via the program MedTech4Health [2016-02211]; University of Gothenburg; Sahlgrenska University Hospital; Karolinska Institutet; Stockholm County Council; Linkoping University and University Hospital; Linkoping University and University Hospital; Swedish government; Swedish government; Lund University; Lund University; Swedish county councils (the ALF agreement); Swedish county councils (the ALF agreement); Skane University Hospital; Skane University Hospital; Division of Primary Health Care of Region Ostergotland; Division of Primary Health Care of Region Ostergotland; Umea University and University Hospital; Umea University and University Hospital; National Research School in General Practice; National Research School in General Practice; Uppsala University and University Hospital; Uppsala University and University Hospital; Swedish Society of Medicine; Swedish Society of Medicine; Swedish Society for Medical Research; Strategic Research Network in Circulation and Metabolism at Linkoping University (LiU-CircM); King Gustaf V and Queen Victoria Freemason Foundation
2025-12-222025-12-222026-01-21